Endocrine Metabolic & Immune Disorders - Drug Targets
Last updated ISSN 1871-5303
Endocrine Metabolic & Immune Disorders - Drug Targets is published by Bentham Science Publishers in medicine. It is a subscription journal. Its article processing charge is not published.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Endocrine Metabolic & Immune Disorders - Drug Targets is — and show you journals like it.
What it publishes
Recent work in Endocrine Metabolic & Immune Disorders - Drug Targets concentrates on these topics, taken from its published record rather than from its own description:
- Thyroid Disorders and Treatments
- Adipokines, Inflammation, and Metabolic Diseases
- Diabetes and associated disorders
- Thyroid Cancer Diagnosis and Treatment
- Natural Antidiabetic Agents Studies
- Diabetes Treatment and Management
- Vitamin D Research Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Gut microbiota and health
- Pituitary Gland Disorders and Treatments
Key facts
| Publisher | Bentham Science Publishers |
|---|---|
| ISSN | 1871-5303, 2212-3873 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | Not published |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 2,149 |
| Publishing since | 2006 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Endocrine Metabolic & Immune Disorders - Drug Targets
Other established journals in medicine, if this one is not the right home for your paper: